Rearrangement of Influenza Virus Spliced Segments for the Development of Live-Attenuated Vaccines

被引:43
作者
Nogales, Aitor [1 ]
DeDiego, Marta L. [1 ,2 ]
Topham, David J. [1 ,2 ]
Martinez-Sobrido, Luis [1 ]
机构
[1] Univ Rochester, Dept Microbiol & Immunol, Rochester, NY 14627 USA
[2] Univ Rochester, David Smith Ctr Immunol & Vaccine Biol, Rochester, NY USA
关键词
A VIRUS; MESSENGER-RNA; M1; PROTEIN; M2; B VIRUS; REPLICATION; CHANNEL; PREVENTION; PROTECTION; MECHANISM;
D O I
10.1128/JVI.00410-16
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Influenza viral infections represent a serious public health problem, with influenza virus causing a contagious respiratory disease which is most effectively prevented through vaccination. Segments 7 (M) and 8 (NS) of the influenza virus genome encode mRNA transcripts that are alternatively spliced to express two different viral proteins. This study describes the generation, using reverse genetics, of three different recombinant influenza A/Puerto Rico/8/1934 (PR8) H1N1 viruses containing M or NS viral segments individually or modified M or NS viral segments combined in which the overlapping open reading frames of matrix 1 (M1)/M2 for the modified M segment and the open reading frames of nonstructural protein 1 (NS1)/nuclear export protein (NEP) for the modified NS segment were split by using the porcine teschovirus 1 (PTV-1) 2A autoproteolytic cleavage site. Viruses with an M split segment were impaired in replication at nonpermissive high temperatures, whereas high viral titers could be obtained at permissive low temperatures (33 degrees C). Furthermore, viruses containing the M split segment were highly attenuated in vivo, while they retained their immunogenicity and provided protection against a lethal challenge with wild-type PR8. These results indicate that influenza viruses can be effectively attenuated by the rearrangement of spliced segments and that such attenuated viruses represent an excellent option as safe, immunogenic, and protective live-attenuated vaccines. Moreover, this is the first time in which an influenza virus containing a restructured M segment has been described. Reorganization of the M segment to encode M1 and M2 from two separate, nonoverlapping, independent open reading frames represents a useful tool to independently study mutations in the M1 and M2 viral proteins without affecting the other viral M product.
引用
收藏
页码:6291 / 6302
页数:12
相关论文
共 50 条
[41]   A Possible Path towards Rapid Development of Live-Attenuated SARS-CoV-2 Vaccines: Plunging into the Natural Pool [J].
Todorov, German ;
Uversky, Vladimir N. .
BIOMOLECULES, 2020, 10 (10)
[42]   Complexities in Predicting the Immunogenicity of Live Attenuated Influenza Vaccines [J].
Lindsey, Benjamin B. ;
Hoschler, Katja ;
de Silva, Thushan I. .
CLINICAL INFECTIOUS DISEASES, 2020, 70 (10) :2235-2236
[43]   Comparative Efficacy of Inactivated and Live Attenuated Influenza Vaccines [J].
Monto, Arnold S. ;
Ohmit, Suzanne E. ;
Petrie, Joshua G. ;
Johnson, Emileigh ;
Truscon, Rachel ;
Teich, Esther ;
Rotthoff, Judy ;
Boulton, Matthew ;
Victor, John C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (13) :1260-1267
[44]   Reverse genetics approaches for live-attenuated vaccine development of infectious bursal disease virus [J].
Yang, Hui ;
Ye, Chengjin .
CURRENT OPINION IN VIROLOGY, 2020, 44 :139-144
[45]   Characterisation of a Live-Attenuated Rabies Virus Expressing a Secreted scFv for the Treatment of Rabies [J].
Smith, Samuel P. ;
Shipley, Rebecca ;
Drake, Pascal ;
Fooks, Anthony R. ;
Ma, Julian ;
Banyard, Ashley C. .
VIRUSES-BASEL, 2023, 15 (08)
[46]   Reduced reaction frequencies with repeated inactivated or live-attenuated influenza vaccination [J].
Ohmit, Suzanne E. ;
Gross, Jonathan ;
Victor, John C. ;
Monto, Arnold S. .
VACCINE, 2009, 27 (07) :1050-1054
[47]   Development of antibody-dependent cellular cytotoxicity in response to recombinant and live-attenuated herpes zoster vaccines [J].
Park, Seong Yeon ;
Levin, Myron J. ;
Canniff, Jennifer ;
Johnson, Michael ;
Schmid, D. Scott ;
Weinberg, Adriana .
NPJ VACCINES, 2022, 7 (01)
[48]   Bordetella bronchiseptica Colonization Limits Efficacy, but Not Immunogenicity, of Live-Attenuated Influenza Virus Vaccine and Enhances Pathogenesis After Influenza Challenge [J].
Hughes, Holly R. ;
Brockmeier, Susan L. ;
Loving, Crystal L. .
FRONTIERS IN IMMUNOLOGY, 2018, 9
[49]   The Efficacy of Live Attenuated and Inactivated Influenza Vaccines in Children as a Function of Time Postvaccination [J].
Ambrose, Christopher S. ;
Wu, Xionghua ;
Belshe, Robert B. .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (09) :806-811
[50]   Evaluating α-galactosylceramide as an adjuvant for live attenuated influenza vaccines in pigs [J].
Artiaga, Bianca L. ;
Morozov, Igor ;
Ransburgh, Russell ;
Kwon, Taeyong ;
Balaraman, Velmurugan ;
Indran, Sabarish V. ;
Madrid, Darling Melany De Carvalho ;
Gu, Weihong ;
Henningson, Jamie ;
Ma, Wenjun ;
Richt, Juergen A. ;
Driver, John P. .
ANIMAL DISEASES, 2022, 2 (01)